|
|
|
|
|
1.
338
Accesses
|
Early-onset breast cancer in a Lebanese family with Lynch syndrome due to MSH2 gene mutation
Riad Akoum, Albert Ghaoui, Emile Brihi, Maroun Ghabash, Nicolas Hajjar Hereditary Cancer in Clinical Practice 2009, 7:10 (28 May 2009)
Abstract | Full text | PDF | PubMed
|
|
|
2.
292
Accesses
|
A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome
Ani Kardashian, Julia Fehniger, Jennifer Creasman, Eleanor Cheung, Mary Beattie Hereditary Cancer in Clinical Practice 2012, 10:4 (12 April 2012)
Abstract | Full text | PDF | PubMed
|
|
|
3.
256
Accesses
|
Challenges in the management of a patient with Cowden syndrome: case report and literature review
Inga Melbārde-Gorkuša, Arvīds Irmejs, Dace Bērziņa, Ilze Štrumfa, Arnis Āboliņš, Andris Gardovskis, Signe Subatniece, Genādijs Trofimovičs, Jānis Gardovskis, Edvīns Miklaševičs Hereditary Cancer in Clinical Practice 2012, 10:5 (14 April 2012)
Abstract | Full text | PDF | PubMed
|
|
|
4.
190
Accesses
|
Drug therapy for hereditary cancers
Evgeny N Imyanitov, Vladimir M Moiseyenko Hereditary Cancer in Clinical Practice 2011, 9:5 (6 August 2011)
Abstract | Full text | PDF | PubMed
|
|
|
5.
189
Accesses
|
Principles of genetic predisposition to malignancies
Tadeusz Dębniak, Jan Lubiński Hereditary Cancer in Clinical Practice 2008, 6:69-72 (15 June 2008)
Full text | PDF | PubMed
|
|
|
6.
166
Accesses
|
The R337H mutation in TP53 and breast cancer in Brazil
Magda CB Gomes, Joanne Kotsopoulos, Gutemberg de Almeida, Mauricio M Costa, Roberto Vieira, Firmino de AG Filho, Marcos B Pitombo, Paulo F Leal, Robert Royer, Phil Zhang, Steven A Narod Hereditary Cancer in Clinical Practice 2012, 10:3 (28 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
7.
125
Accesses
|
Unusual presentation of Lynch Syndrome
Veronica PCC Yu, Marco Novelli, Stewart J Payne, Sam Fisher, Rebecca A Barnetson, Ian M Frayling, Ann Barrett, David Goudie, Audrey Ardern-Jones, Ros Eeles, Susan Shanley Hereditary Cancer in Clinical Practice 2009, 7:12 (3 June 2009)
Abstract | Full text | PDF | PubMed
|
|
|
8.
113
Accesses
|
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
Bente A Talseth-Palmer, Mary McPhillips, Claire Groombridge, Allan Spigelman, Rodney J Scott Hereditary Cancer in Clinical Practice 2010, 8:5 (21 May 2010)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
The Australian authors identified 26 different MSH6 and 4 different PMS2 mutations in 35 Lynch syndrome families studied. For MSH6 mutation carriers, the estimated cumulative risk of CRC at age 70 years was 61% (similar in males and females) and 65% for endometrial cancer. The risk of developing CRC was found to be different between males and females at age 50 years: 34% for males and 21% for females.
|
|
|
9.
110
Accesses
|
Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families
Susan T Vadaparampil, Richard P Moser, Jennifer Loud, June A Peters, Mark H Greene, Larissa Korde Hereditary Cancer in Clinical Practice 2009, 7:11 (29 May 2009)
Abstract | Full text | PDF | PubMed
|
|
|
10.
107
Accesses
|
Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers
Ramunas Janavicius, Pavel Elsakov Hereditary Cancer in Clinical Practice 2012, 10:1 (10 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
11.
99
Accesses
|
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang, Steven A Narod, Joanne Kotsopoulos Hereditary Cancer in Clinical Practice 2011, 9:10 (15 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
12.
96
Accesses
|
Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
Dewkoemar Ramsoekh, Anja Wagner, Monique E van Leerdam, Dennis Dooijes, Carli MJ Tops, Ewout W Steyerberg, Ernst J Kuipers Hereditary Cancer in Clinical Practice 2009, 7:17 (23 December 2009)
Abstract | Full text | PDF | PubMed
|
|
|
13.
92
Accesses
|
Primary appendiceal mucinous adenocarcinoma in two first-degree relatives: case report and review
Adrianne R Racek, Kari G Rabe, Myra J Wick, Apostolos Psychogios, Noralane M Lindor Hereditary Cancer in Clinical Practice 2011, 9:1 (4 May 2011)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Published accounts of familial instances of primary appendiceal tumors are strikingly rare. The authors report two siblings who both developed primary mucinous adenocarcinomas, and found one additional affected sib-pair among 316 cases of primary appendiceal cancer of any histologic type recorded in the Mayo clinic. Although these cases may be coincidental, an exceedingly rare predisposition syndrome cannot be ruled out.
|
|
|
14.
89
Accesses
|
Familial Multiple Myeloma: Report on Two Families and Discussion of Screening Options
Erica H Gerkes, Mirjam M de Jong, Rolf H Sijmons, Edo Vellenga Hereditary Cancer in Clinical Practice 2007, 5:72-78 (15 June 2007)
Abstract | Full text | PDF | PubMed
|
|
|
15.
88
Accesses
|
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
AJ Gill Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A7 (12 April 2012)
Full text | PDF
|
|
|
16.
87
Accesses
|
Close ties: an exploratory Colored Eco-Genetic Relationship Map (CEGRM) study of social connections of men in Familial Testicular Cancer (FTC) families
June A Peters, Regina Kenen, Lindsey M Hoskins, Gladys M Glenn, Christian Kratz, Mark H Greene Hereditary Cancer in Clinical Practice 2012, 10:2 (1 March 2012)
Abstract | Full text | PDF | PubMed
|
|
|
17.
87
Accesses
|
How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study
Louise A Keogh, Belinda J McClaren, Carmel Apicella, John L Hopper, the Australian Breast Cancer Family Study Hereditary Cancer in Clinical Practice 2011, 9:7 (6 September 2011)
Abstract | Full text | PDF | PubMed
|
|
|
18.
85
Accesses
|
IDH1 mutation analysis – an example of putative glioma marker
Marzena Lewandowska, T Szylberg, K Roszkowski, J Furtak, W Windorbska, J Rytlewska, W Jóźwicki Hereditary Cancer in Clinical Practice 2012, 10(Suppl 3):A14 (20 April 2012)
Full text | PDF
|
|
|
19.
84
Accesses
|
Factors Influencing Cancer Risk Perception in High Risk Populations: A Systematic Review
Jon C Tilburt, Katherine M James, Pamela S Sinicrope, David T Eton, Brian A Costello, Jantey Carey, Melanie A Lane, Shawna L Ehlers, Patricia J Erwin, Katherine E Nowakowski, Mohammad H Murad Hereditary Cancer in Clinical Practice 2011, 9:2 (19 May 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Patients at higher than average risk of heritable cancer may process risk information differently than the general population. However, little is known about clinical, demographic, or psychosocial predictors that may impact risk perception in these groups. The authors from the Mayo clinic searched literature databases for published research on these topics. Family history of cancer, previous prophylactic tests and treatments, and younger age have been shown to be associated with cancer risk perception. In addition, beliefs about the preventability and severity of cancer, personality factors such as "monitoring" personality, the ability to process numerical information, as well as distress/worry also were associated with cancer risk perception. Few studies addressed non-breast cancer or risk perception in specific demographic groups (e.g. elderly or minority groups) and few employed theory-driven analytic strategies to decipher interrelationships of factors. Clearly, there is need for additional studies.
|
|
|
20.
83
Accesses
|
Encyclopaedia of tumour-associated familial disorders. Part I: from AIMAH to CHIME syndrome
Rolf H Sijmons Hereditary Cancer in Clinical Practice 2008, 6:22-57 (15 March 2008)
Abstract | Full text | PDF | PubMed
|
|
|
21.
81
Accesses
|
Familial paragangliomas
CJM Lips, EGWM Lentjes, JWM Höppener, RB Luijt, FL Moll Hereditary Cancer in Clinical Practice 2006, 4:169-176 (15 October 2006)
Abstract | Full text | PDF | PubMed
|
|
|
22.
78
Accesses
|
Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario
Yun-Hee Choi, Michelle Cotterchio, Gail McKeown-Eyssen, Monga Neerav, Bharati Bapat, Kevin Boyd, Steven Gallinger, John McLaughlin, Melyssa Aronson, Laurent Briollais Hereditary Cancer in Clinical Practice 2009, 7:14 (23 August 2009)
Abstract | Full text | PDF | PubMed
|
|
|
23.
77
Accesses
|
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests
Marielle AE Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, Fiona Lennard, Paul Pharoah, Ian Jacobs, Ann Ward, Desmond PJ Barton, Thomas EJ Ind, John H Shepherd, Jane E Bridges, Martin Gore, Chris Haracopos, Susan Shanley, Audrey Ardern-Jones, Sarah Thomas, Ros Eeles Hereditary Cancer in Clinical Practice 2011, 9:11 (23 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
24.
77
Accesses
|
Lynch syndrome: barriers to and facilitators of screening and disease management
Kathy E Watkins, Christine Y Way, Jacqueline J Fiander, Robert J Meadus, Mary Esplen, Jane S Green, Valerie C Ludlow, Holly A Etchegary, Patrick S Parfrey Hereditary Cancer in Clinical Practice 2011, 9:8 (7 September 2011)
Abstract | Full text | PDF | PubMed
|
|
|
25.
75
Accesses
|
Molecular genetics analysis of hereditary breast and ovarian cancer patients in India
Nagasamy Soumittra, Balaiah Meenakumari, Tithi Parija, Veluswami Sridevi, Karunakaran N Nancy, Rajaraman Swaminathan, Kamalalayam R Rajalekshmy, Urmila Majhi, Thangarajan Rajkumar Hereditary Cancer in Clinical Practice 2009, 7:13 (6 August 2009)
Abstract | Full text | PDF | PubMed
|
